Literature DB >> 11436166

A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature.

E Paal1, L D Thompson, R A Frommelt, R M Przygodzki, C S Heffess.   

Abstract

Anaplastic pancreatic carcinomas are rare tumors, frequently displaying a variety of growth patterns. The literature lacks a comprehensive study of this tumor. Thirty-five cases of anaplastic carcinoma of the pancreas diagnosed between 1955 and 1997 were retrieved from the Endocrine Registry at the Armed Forces Institute of Pathology. Histology, immunophenotype, molecular analysis, and patient follow-up were analyzed. The tumors of 10 women and 25 men, aged 34 to 85 years (mean age at presentation, 62.5 years), were studied. Patients had vague symptoms (weight loss, pain, and fatigue, nausea, or vomiting), lasting an average of 13.2 weeks. The tumors, of an average size of 9.2 cm, were usually in the head or tail of the pancreas. The tumors were widely infiltrative, histomorphologically separated into predominantly large, pleomorphic cell, or spindle cell groups. Tumor phagocytosis and necrosis were noted. Immunohistochemical studies confirmed an epithelial origin with at least one epithelial marker in 78% of the tumors. K-ras mutations by sequence analysis were found in eight of 12 cases tested. Surgical biopsy/excision was used in all patients. Twenty-nine of 35 patients died of disease (average, 5.2 months), three died with no evidence of disease (average, 56.9 months), and three patients were alive at last follow-up (average, 94.0 months), one with residual disease. There was no statistically significant difference in survival between patients with and without a K-ras mutation. Anaplastic carcinoma of the pancreas usually occurs in the head of the pancreas in older men. The epithelial nature of the pleomorphic cells (giant or spindled) can usually be documented. Patients with K-ras mutations have a shorter survival time, even though the overall prognosis for all anaplastic carcinomas is fatal (93% fatality; average survival, 448 days). Ann Diagn Pathol 5: 129-140, 2001. This is a US government work. There are no restriction on its use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436166     DOI: 10.1053/adpa.2001.25404

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  37 in total

1.  Anaplastic adenocarcinoma of the pancreas.

Authors:  Nickos Michalopoulos; Styliani Laskou; Yiorgos Papadakis; Georgia Karayannopoulou; Ioannis Kanellos
Journal:  J Gastrointest Cancer       Date:  2015-03

2.  [Mesenchymal tumors of the pancreas. Surprising, but not uncommon].

Authors:  U Pauser; M Kosmahl; B Sipos; G Klöppel
Journal:  Pathologe       Date:  2005-02       Impact factor: 1.011

3.  Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Authors:  Aatur D Singhi; Raja R Seethala; Katie Nason; Tyler J Foxwell; Robyn L Roche; Kevin M McGrath; Ryan M Levy; James D Luketich; Jon M Davison
Journal:  Hum Pathol       Date:  2014-12-17       Impact factor: 3.466

4.  Anaplastic Carcinoma of the Pancreas: A Rare Clinical Entity.

Authors:  Erkan Oymaci; Savas Yakan; Mehmet Yildirim; Asuman Argon; Ozan Namdaroglu
Journal:  Cureus       Date:  2017-10-18

5.  Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated.

Authors:  Takashi Muraki; Michelle D Reid; Olca Basturk; Kee-Taek Jang; Gabriela Bedolla; Pelin Bagci; Pardeep Mittal; Bahar Memis; Nora Katabi; Sudeshna Bandyopadhyay; Juan M Sarmiento; Alyssa Krasinskas; David S Klimstra; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

6.  Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.

Authors:  Jan Hrudka; Kateřina Lawrie; Petr Waldauf; Vanda Ciprová; Jana Moravcová; Radoslav Matěj
Journal:  Virchows Arch       Date:  2020-05-18       Impact factor: 4.064

7.  Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structures.

Authors:  Naoto Kuroda; Shin-Ichi Iwamura; Nokiaki Fujishima; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

Review 8.  Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a rare case report and review of the literature.

Authors:  Shambhu K Sah; Ying Li; Yongmei Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  A case report of anaplastic carcinoma of the pancreas with remarkable intraductal tumor growth into the main pancreatic duct.

Authors:  Mitsuyoshi Okazaki; Isamu Makino; Hirohisa Kitagawa; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Tetsuo Ohta
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report.

Authors:  Atsushi Nakajima; Hirokazu Takahashi; Masahiko Inamori; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Shoji Yamanaka
Journal:  J Med Case Rep       Date:  2008-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.